Ake Hansasuta
Papers
5
Total Citations
76
H-Index
4
About
Dr. Ake Hansasuta is a leading figure in stereotactic radiosurgery, whose work has significantly advanced the treatment of complex intracranial tumors and vascular malformations. His primary research focuses on the clinical application of the CyberKnife robotic radiosurgery system, particularly for conditions where precision is paramount. Dr. Hansasuta’s major contributions include demonstrating the efficacy and safety of hypofractionated stereotactic radiotherapy (HSRT) for perioptic pituitary adenomas, a challenging area due to the optic pathway's radiation sensitivity. His landmark 2015 paper on this topic, with 32 citations, established a critical treatment paradigm. He has further validated these techniques for vestibular schwannoma, with a 2021 study (13 citations) providing long-term outcomes, and for brain arteriovenous malformations (AVMs), where his work on 170 cases (8 citations) showcases frameless image-guided precision. His cumulative research, including recent work on bilateral schwannomas in neurofibromatosis type 2 patients, has collectively garnered over 70 citations, underscoring his impact. Dr. Hansasuta’s work is notable for its focus on long-term clinical outcomes, providing essential data that guides modern radiosurgical practice and improves patient quality of life.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5